Allergy and Asthma Proceedings

Papers
(The median citation count of Allergy and Asthma Proceedings is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Impact of steroids on the immune profiles of children with asthma living in the inner-city33
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination28
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis26
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children24
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis23
Operationalizing shared decision making in clinical practice21
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being21
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study20
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks20
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts20
For the Patient18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202218
For the Patient17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes17
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy15
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity15
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma15
Evaluation and management of chronic cough in adults15
Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays15
Recurrent full-body rash following chemotherapy initiation in a multiple myeloma patient14
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy13
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis13
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps13
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course13
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome12
Diagnostic utility of basophil CD203c expression in β-lactam allergy12
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics12
For the Patient12
Effects of mechanical washing and drying on the removal of pet allergens12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department12
Utility of basophil activation tests in the diagnosis of cross-intolerance to nonsteroidal anti-inflammatory drug reactions12
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?11
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment11
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii11
Navigating the management complexity in long-term asymptomatic immunodeficiency11
A tribute to allergy and immunology fellowship training program directors and to the fellows they train11
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab10
For the patient10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities10
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination9
The long COVID syndrome: A conundrum for the allergist/immunologist9
Hematopoietic stem cell transplantation for primary immunodeficiency9
Metal implant allergy: A retrospective cohort analysis at a university allergy practice9
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study9
Evaluation of atopic diseases in patients with allergic contact dermatitis9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible9
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii9
Primary Immunodeficiency: Specific antibody deficiency with normal IgG9
For the Patient8
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis8
Benralizumab in the management of rare primary eosinophilic lung diseases8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization8
Rethinking the management of hereditary angioedema8
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization8
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review8
Overview of secondary immunodeficiency8
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab8
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH8
Curcumin does not significantly affect immediate skin tests8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives8
The impact of dietary patterns on the risk of asthma in children8
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience7
Patterns of epinephrine prescribing at discharge and length of stay for adult anaphylaxis in U.S. emergency departments7
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations7
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study7
Immunodeficiency: Burden of Illness7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort7
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis7
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis7
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan7
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough7
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic7
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)7
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience7
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers7
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis7
Winged hymenoptera: Discordance between In vitro and In vivo sensitization7
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis6
A masquerade of recurrent anaphylaxis6
For the patient6
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma6
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria6
Genetically-determined defects of T cell development6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor6
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida6
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis6
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis6
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease6
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis6
Clinical implications of asthma endotypes and phenotypes5
Comparison of clinical characteristics in primary immunodeficiency patients based on the presence of autoimmunity or autoinflammation5
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan5
Expanding horizons of omalizumab: New frontiers in asthma and beyond5
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies5
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease5
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines5
Successful rapid liposomal amphotericin B desensitization in pediatric case series5
Safety of dupilumab use during pregnancy: A composite evaluation of pregnancy outcomes5
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors5
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema5
Peptide immunotherapy for aeroallergens5
Treatment options for moderate to severe atopic dermatitis5
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study5
Cat allergy in children and the effect of the COVID-19 pandemic5
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience5
Anaphylaxis: Long-term management and resources5
Comprehensive assessment of allergic manifestations including drug hypersensitivity in adult patients with inborn errors of immunity5
The COVID-19 impact on severe uncontrolled asthma costs and biologic use5
Comorbidity burden in patients with anaphylaxis: A 25-year nationwide population-based matched case‐control study5
Integrating innovation and shared decision-making in allergy and immunology practice4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy4
Allergy immunotherapy for allergic fungal respiratory diseases4
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches4
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children4
The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level4
Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics4
The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites4
In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites4
Comparative analysis of demographic and clinical features in common variable immunodeficiency and selective immunoglobulin G deficiency4
Is atopic comorbidity increased in proctocolitis?4
Assessment of mask use on oxygen saturation in adults and children with asthma4
Atopic dermatitis: Best of guidelines and yardstick4
Reply4
Across the arc of allergy: From maternal immune tolerance to food sensitization pathways and lifesaving anaphylaxis care4
Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low4
For the patient4
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children4
Aeroallergen immunotherapy update: Developments since the third Practice Parameter4
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis4
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma4
Management and referral patterns for new-onset chronic cough in primary care patients4
An infant with chronic relapsing urticaria4
Unmasking multifactorial dermatitis: The case for comprehensive diagnostic guidelines in adult atopic dermatitis4
Treatment of eosinophilic esophagitis with immune modulating agents4
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance3
For the patient3
Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China3
The challenge of neurologic disease for the allergist/immunologist3
Caregiver perceptions of β-lactam allergy testing for serum sickness-like reactions3
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts3
Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review3
Capturing total steroid burden in patients with atopic dermatitis and asthma3
Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospecti3
Health disparities investigated in a primary care penicillin allergy removal pathway3
The complexities of allergic diseases continue to challenge the allergist-immunologist3
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases3
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation3
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency3
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD3
The medical management of chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory in the biologic age3
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease3
Managing food allergies in each stage of life3
Allergic comorbidities in fibromyalgia3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist3
The utility of shared decision making in the management of hereditary angioedema3
Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria3
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test3
Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience3
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes3
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub3
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts3
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies3
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings3
Oral immunotherapy with sunflower seed butter and a review of seed allergy3
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐20183
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing3
0.12226796150208